📰 Archives & Recherche

🇬🇧 Royaume-Uni • Science

🔍 Rechercher dans les archives

📊 1,365 articles archivé(s)
Page 33 / 69

Chiesi snags on-demand HAE drug in $1.9B Kalvista buy

A preview of the next edition of BioWorld, April 29, 2026...

Brits' top 10 rituals to keep bad luck at bay - from crossing fingers to 'lucky' outfits

Brits' top 10 rituals to keep bad luck at bay - from crossing fingers to 'lucky' outfits

New research reveals the top 10 rituals and superstitions Brits stick to in order to keep bad luck at bay - or create a bit of extra...

Low Earth Orbit Could Spiral Into Chaos In Just 72 Hours, Scientists Warn - The Daily Galaxy

Low Earth Orbit Could Spiral Into Chaos In Just 72 Hours, Scientists Warn The Daily Galaxy 2.8 Days to Disaster: Scientists Warn Low Earth Orbit Could...

US research reactor first to produce electricity

In the coming months, the University of Utah's TRIGA research reactor will be used to produce electricity to power a mini AI data centre as part of pr...

Oldest burial in Patagonia reveals early human settlement along South America's Atlantic coast

Oldest burial in Patagonia reveals early human settlement along South America's Atlantic coast

The peopling of South America has long been debated, with various routes proposed for how they spread across the subcontinent. However, routes along t...

Top 20 signs of the 'Sisterhood Code' which 'speak volumes'

Top 20 signs of the 'Sisterhood Code' which 'speak volumes'

New research has uncovered the secret sisterhood code – from unspoken eye contact to bathroom solidarity – and the ways women support each other e...

The Retirement Plan That Fails Millions — Why Working Longer Isn't Enough Anymore

The Retirement Plan That Fails Millions — Why Working Longer Isn't Enough Anymore

New research reveals that working longer is not a reliable retirement plan. Many retire earlier than expected due to health issues or layoffs, highlig...

Astrazeneca unveils safer CD8-guided TCE for prostate cancer

T-cell engagers (TCEs) drive synthetic antitumor immunity by bypassing endogenous T-cell priming and directly inducing tumor cell killing. In prostate...

CIRM grant to help advance Acurastem’s AS-241 toward clinic

CIRM grant to help advance Acurastem’s AS-241 toward clinic

Acurastem Inc. has been awarded $7.5 million in grant funding by the California Institute for Regenerative Medicine (CIRM) to support the advancement ...

A new prodrug approach overcomes trofinetide’s limitations

A new prodrug approach overcomes trofinetide’s limitations

Rett syndrome (RTT) is a rare neurodevelopmental condition affecting multiple organ systems and is most often driven by mutations in the X-linked MECP...

Addex’s GABA-B PAM studied in IPF-related chronic cough model

Addex’s GABA-B PAM studied in IPF-related chronic cough model

Addex Therapeutics Ltd. has released preclinical data demonstrating antitussive activity of its γ-aminobutyric acid subtype B receptor (GABA-B) posit...

Montai’s MTAI-1025 demonstrates efficacy in ulcerative colitis

Montai’s MTAI-1025 demonstrates efficacy in ulcerative colitis

The combination of impaired epithelial barrier function, mucosal inflammation and elevated oxidative stress is determinant for the pathogenesis of ulc...

Avelos Therapeutics discovers new POLθ inhibitors

Avelos Therapeutics Inc. has patented new seleno-fused hetero ring DNA polymerase θ (POLθ) inhibitors potentially useful for the treatment of cancer...

Astrazeneca divulges new ADCs for cancer

Astrazeneca AB has reported new antibody-drug conjugates (ADCs) comprising an antibody or antigen-binding fragment covalently linked to cytotoxic drug...

New cGAS inhibitors reported in Riltide Medicines patent

Riltide Medicines Co. Ltd. has identified new cyclic GMP-AMP synthase (MB21D1; cGAS) inhibitors potentially useful for the treatment of autoimmune dis...

Foshan Ionova Biotherapeutics identifies new IL-17A inhibitors

Foshan Ionova Biotherapeutics Co. Ltd. has discovered new interleukin-17A (IL-17A) inhibitors potentially useful for the treatment of inflammatory dis...

Shanghai Yingli Pharmaceutical synthesizes new OGG1 inhibitors

Shanghai Yingli Pharmaceutical Co. Ltd. has divulged new nitrogen-containing heterocyclic compounds acting as N-glycosylase/DNA lyase (OGG1) inhibitor...

How the changing face of farming is reflected in Scotland's election

How the changing face of farming is reflected in Scotland's election

The rural vote is a significant, but often overlooked, constituency in the Scottish Parliament election....

More deaths than births expected in UK over next 10 years as population growth slows

More deaths than births expected in UK over next 10 years as population growth slows

The UK population is projected to grow more slowly than previously predicted over the next few decades, driven by lower net migration, before starting...

Investigating the disordered heart of glass

Recent research led by the University of Trento reveals that fundamental atomic vibrations remain unchanged also in ultra-stable glasses. This discove...